Can Seroquel XR Be Dosed Entirely at Night?
Yes, the entire dose of Seroquel XR (quetiapine extended-release) should be administered once daily, preferably in the evening, according to FDA labeling. 1
FDA-Approved Dosing Schedule
The FDA drug label explicitly states that SEROQUEL XR should be administered once daily, preferably in the evening 1. This is the official recommendation across all approved indications including:
- Schizophrenia (400-800 mg/day)
- Bipolar disorder manic/mixed episodes (400-800 mg/day)
- Bipolar depression (300 mg/day)
- Major depressive disorder adjunctive therapy (150-300 mg/day)
Key Administration Requirements
The tablets must be swallowed whole and cannot be split, chewed, or crushed 1. This is critical because breaking the tablet destroys the extended-release mechanism.
Take without food or with a light meal only (approximately 300 calories). A high-fat meal significantly increases absorption (higher AUC and Cmax), while a light meal has no significant effect 1, 2.
Pharmacokinetic Rationale
The extended-release formulation was specifically designed for once-daily dosing 2. Compared to immediate-release quetiapine given twice daily, Seroquel XR provides:
- Similar total daily exposure (AUC) and minimum plasma concentration (Cmin)
- Slightly lower maximum plasma concentration (Cmax)
- Less variable drug levels (39.2% vs 51.2% coefficient of variation) 2
- More sustained D2 receptor occupancy with less pronounced peaks 2
Clinical Advantages of Evening Dosing
Significantly reduced daytime sedation is the primary benefit. Studies demonstrate that evening dosing of Seroquel XR produces lower sedation intensity in the first 1-3 hours post-dose compared to immediate-release formulations, with similar sedation 4-14 hours later 3. This allows patients to sleep through the peak sedative effects while maintaining therapeutic drug levels during waking hours.
Common Pitfall to Avoid
Do not split the daily dose into multiple administrations. This defeats the purpose of the extended-release formulation and converts it functionally back to immediate-release dosing with unpredictable pharmacokinetics. The once-daily evening schedule is both the FDA-approved method and the clinically optimal approach for efficacy and tolerability.